Skip to NavigationSkip to content

Cellzome hires GSK's Alan Watt

Published on: 20/09/10

Cambridge, UK-based drug discovery and development company Cellzome has appointed Alan Watt to its senior management team as vice president of therapeutics.

Alan joins the company from GlaxoSmithKline, where he was most recently vice president of the company’s Immuno-Inflammation Centre of Excellence for Drug Discovery.

Prior to his time with GSK Alan held various positions at Merck Sharp & Dohme, starting as medicinal chemist, moving into analytical chemistry and finally leading the drug metabolism department as senior director until he left in 2006.

Cellzome’s chief executive Tim Edwards said: “We are delighted that Alan has joined Cellzome. In his 25 years of experience in the industry he has delivered numerous development candidates into the clinic. His experience will help us to fully leverage our chemical proteomics platform.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches